Stocks · Health care · Pharmaceutical Preparations

PHIBRO ANIMAL HEALTH CORP

PAHC Clue Score66
United States Fiscal year ends June CIK 0001069899 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

By person

10 insiders · 106 transactions
0.8×

Daniel M. Bendheim holds only 0.8 times base salary in stock. $482.17K of shares against $575.00K in salary for 2026.

Salary from the company's own proxy. The shares are what Daniel M. Bendheim last reported holding, valued at $31.77, the price Class A Common Stock was last bought or sold at on the open market here, on 29 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Jack Bendheim
Executive Chairman
—
$27.85M (105) scheduled
−$27.85M
82,792
0.204%
$2.63M
+39.2%
E Thomas Corcoran
Director
$317.70K (1)
—
+$317.70K
41,459
0.102%
$1.32M
+56.7%
Glenn David
Chief Financial Officer
—
—
—
54,811
0.135%
$1.74M
—
Larry Lee Miller
Chief Operating Officer
—
—
—
38,071
0.094%
$1.21M
+26.9%
Daniel M Bendheim
President and CEO
—
—
—
15,177
0.037%
$482.17K
—
Jonathan BENDHEIM
Director
—
—
—
5,984
0.015%
$190.11K
—
Judith Weinstein
See Remarks
—
—
—
5,453
0.013%
$173.24K
—
Lisa Ann Escudero
See Remarks
—
—
—
3,434
0.008%
$109.10K
—
Anthony Andolino
See Remarks
—
—
—
1,793
0.004%
$56.96K
—
Patrick Rodriguez
VP Finance and Treasurer
—
—
—
1,503
0.004%
$47.75K
—